Tatsuro Ishibashi

Person

Fukuoka-shi, JP

People

Patents Grantslast 30 patents

Information Patent Grant
Therapeutic agent for ocular fundus disease
- Patent number 10,426,783
- Issue date Oct 1, 2019
- KYUSHU UNIVERSITY, NAT'L UNIVERSITY CORPORATION
- Tatsuro Ishibashi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Staining composition for staining an ophthalmic membrane
- Patent number 7,731,941
- Issue date Jun 8, 2010
- National University Corporation Kyushu University
- Hiroshi Enaida
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
- Publication number 20240216390
- Publication date Jul 4, 2024
- KYUSHU UNIVERSITY, NAT'L UNIVERSITY CORPORATION
- Tatsuro Ishibashi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTER...
- Publication number 20210163608
- Publication date Jun 3, 2021
- OSAKA UNIVERSITY
- Nobuyuki Ohguro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
- Publication number 20190365776
- Publication date Dec 5, 2019
- KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
- Tatsuro Ishibashi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
- Publication number 20170100409
- Publication date Apr 13, 2017
- KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
- Tatsuro Ishibashi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
- Publication number 20160339018
- Publication date Nov 24, 2016
- KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
- Tatsuro Ishibashi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTER...
- Publication number 20160326255
- Publication date Nov 10, 2016
- OSAKA UNIVERSITY
- Nobuyuki Ohguro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin...
- Publication number 20150105442
- Publication date Apr 16, 2015
- AQUA Therapeutics Co., Ltd.
- Shigeo Yoshida
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
- Publication number 20140378441
- Publication date Dec 25, 2014
- KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
- Tatsuro Ishibashi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTER...
- Publication number 20100129355
- Publication date May 27, 2010
- OSAKA UNIVERSITY
- Nobuyuki Ohguro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF INHIBITING ANGIOGENESIS BY USING EPHRIN B2
- Publication number 20090270315
- Publication date Oct 29, 2009
- AQUMEN BIOPHARMACEUTICALS K.K.
- Kimihiko Fujisawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Suppressing Neovascularization Using Ephrinb2
- Publication number 20090042778
- Publication date Feb 12, 2009
- Aqumen Biopharmaceuticals K.K.
- Kimihiko Fujisawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Staining Composition For Staining An Ophthalmic Membrane
- Publication number 20080090914
- Publication date Apr 17, 2008
- National University Corporation Kyushu University
- Hiroshi Enaida
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Tatsuro Ishibashi

Person

Patents Grantslast 30 patents

Therapeutic agent for ocular fundus disease

Staining composition for staining an ophthalmic membrane

Patents Applicationslast 30 patents

THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTER...

THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE

THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE

THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTER...

Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin...

THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTER...

METHOD OF INHIBITING ANGIOGENESIS BY USING EPHRIN B2

Methods for Suppressing Neovascularization Using Ephrinb2

Staining Composition For Staining An Ophthalmic Membrane